Drug Trial Radar · NCT03986138
Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)
Last checked: Nov 20, 2026Latest source record: Oct 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
324
Actual
Start
Aug 27, 2019
Primary completion
Dec 9, 2020
Study completion Dec 9, 2020
Sponsor
- Lead sponsor
- GuerbetIndustry
- Sponsor type
- Industry
- First posted
- Jun 14, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The trial aimed at evaluating the efficacy and the safety of gadopiclenol for body Magnetic resonance Imaging (MRI)
Conditions
- Lesion in Body Region
Interventions
gadopiclenolDrug
Single intravenous bolus injection
Gadobutrol 1 MMOLE/ML Intravenous SolutionDrug
Single intravenous bolus injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Lesion Visualization Comparing Gadopiclenol-enhanced MRI to Unenhanced MRITime frame: At first MRI examination (gadopiclenol-enhanced MRI) for patients of Arm 1. At second MRI examination (gadopiclenol-enhanced MRI) for patients of Arm 2, performed 2-14 days after gadobutrol-enhanced MRI.
Locations
33 sites in 11 countries. Site status is shown where the registry gives one.
The University of Alabama at Birmingham
Birmingham, Alabama
UConn Health - University of Connecticut
Farmington, Connecticut
The University of Chicago Medical Center
Chicago, Illinois
Boston Medical Center
Boston, Massachusetts
University of Missouri Health System
Columbia, Missouri
Montefiore Medical Center
The Bronx, New York
UT Health San Antonio
San Antonio, Texas
Acibadem City Clinic Tokuda Hospital Sofia
Sofia, Bulgaria
CHU
Angers, France
CHU Beaujon
Clichy, France
Hôpital Saint Louis
Paris, France
Klinik für Diagnostische und Interventionelle Radiologie
Aachen, Germany
Universitätsklinikum Halle
Halle, Germany
Universitätsklinikum des Saarlandes
Homburg, Germany
University Hospital Jena
Jena, Germany
Somogy Megyei Kaposi Mor Oktato Korhaz
Kaposvár, Hungary
Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet
Szolnok, Hungary
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Naples, Italy
Clinical Research Institute S.C.
Estado de México, Mexico
Axis Heilsa S de R.L. de C.V - Althian Clinical Research Management Center
Monterrey, Mexico
Szpital Uniwersytecki Nr 1 im. dr Antoniego Jurasza w Bydgoszczy
Bydgoszcz, Poland
Uniwersyteckie Centrum Kliniczne
Gdansk, Poland
Jagiellońskie Centrum Innowacji Sp. z o. o.
Krakow, Poland
Szpital Świętego Rafała
Krakow, Poland
Centrum Medyczne Affidea Wałbrzych
Wałbrzych, Poland
Inje University Busan Paik Hospital
Busan, South Korea
Bucheon Suncheonhyang Hospital
Gyeonggi-do, South Korea
Korea University Anam Hospital
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Hospital Universitario y Politécnico La Fe
Valencia, Spain
St. Luke's Hospital
Kropyvnytskyi, Ukraine
Borys Clinic
Kyiv, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.